News of the Senate vote on tax reform last week buried another headline, one that could be just as momentous in remaking an entire sector of the American economy. Health insurer Aetna (NYSE: AET) has agreed to an acquisition by CVS Health (NYSE: CVS) in a $68 billion deal that could transform the healthcare industry. The addition of Aetna’s 22 million insurance customers will create one of the most vertically-integrated behemoths in the industry when added to CVS’s nation-wide pharmacy business, pharmaceutical benefits manager (PBM), and retail medical services. The ability to insure, negotiate drug prices,… Read More
News of the Senate vote on tax reform last week buried another headline, one that could be just as momentous in remaking an entire sector of the American economy. Health insurer Aetna (NYSE: AET) has agreed to an acquisition by CVS Health (NYSE: CVS) in a $68 billion deal that could transform the healthcare industry. The addition of Aetna’s 22 million insurance customers will create one of the most vertically-integrated behemoths in the industry when added to CVS’s nation-wide pharmacy business, pharmaceutical benefits manager (PBM), and retail medical services. The ability to insure, negotiate drug prices, and deliver health services and pharmaceuticals to customers could create a new standard in healthcare delivery. This, combined with financial tailwinds from the potential tax reform package, could set off a wave of merger activity in 2018. #-ad_banner-#And I’ve found three leaders that could be prime investment targets. How Could This $68 Billion Mega-Deal Reshape Healthcare? At $68 billion in cash and stock, the deal is more than twice the size of the next largest M&A deal so far this year. More than the size of the tie-up, the deal could have major significance for… Read More